Publications by authors named "Margrethe L Storm"

Background: SARS-CoV-2 reinfection rates have been shown to vary depending on the circulating variant, vaccination status and background immunity, as well as the time interval used to identify reinfections. This study describes the frequency of SARS-CoV-2 reinfections in Norway using different time intervals and assesses potential factors that could impact the risk of reinfections during the different variant waves.

Methods: We used linked individual-level data from national registries to conduct a retrospective cohort study including all cases with a positive test for SARS-CoV-2 from February 2020 to January 2022.

View Article and Find Full Text PDF

We included 39,524 COVID-19 Omicron and 51,481 Delta cases reported in Norway from December 2021 to January 2022. We estimated a 73% reduced risk of hospitalisation (adjusted hazard ratio: 0.27; 95% confidence interval: 0.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the hospitalization risk of the Delta and Alpha variants of COVID-19 in Norway, focusing on vaccination status.
  • Researchers analyzed 19,055 lab-confirmed cases of SARS-CoV-2 from May to August 2021, finding similar hospitalization risks for both variants.
  • The study concluded that vaccination significantly reduces hospitalization risk, with partially vaccinated individuals having a 72% reduced risk and fully vaccinated individuals having a 76% reduced risk compared to unvaccinated cases.
View Article and Find Full Text PDF

Background: Rapid antigen tests (RATs) may be included in national strategies for handling the SARS-CoV-2 pandemic, as they provide test results rapidly, are easily performed outside laboratories, and enable immediate contract tracing. However, before implementation further clinical evaluation of test sensitivity is warranted.

Objectives: To examine the performance of Abbott's Panbio™ COVID-19 Ag Rapid Test Device for SARS-CoV-2 testing in a low to medium prevalence setting in Norway.

View Article and Find Full Text PDF

TCTP has been implicated in a plethora of important cellular processes related to cell growth, cell cycle progression, malignant transformation and inhibition of apoptosis. In addition to these intracellular functions, TCTP has extracellular functions and plays an important role in immune cells. TCTP expression was previously shown to be deregulated in prostate cancer, but its function in prostate cancer cells is largely unknown.

View Article and Find Full Text PDF